D-0412-2018 Class III Terminated

Recalled by AbbVie Inc. — North Chicago, IL

FDA drug recall D-0412-2018 was initiated by AbbVie Inc. on Jan 22, 2018 and is designated Class III. Reason for recall: Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage. The recall status is terminated (terminated Sep 13, 2018). Affected quantity: 7,770 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 7, 2018
Initiation Date
Jan 22, 2018
Termination Date
Sep 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,770 bottles

Product description

Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51

Reason for recall

Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.

Distribution pattern

MS, OH

Code information

Lot #: 1088856, Exp 6/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0412-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0412-2018. Report a data issue: hello@regdatalab.com.